Four Years in PEN: We Lived the Failure, the Downgrades, the Rebuild — Now the Company Finally Looks Like an Operator
I entered Peninsula in December 2021, long before the reset, long before the low‑pH restart, long before the new board and new CEO. I’ve lived the full arc — including the parts most people never experienced. I’ve been riding the broader nuclear wave for years, and PEN was one of the names I backed early.
Phase 1 — The False Start (2021–2024)
The original plan failed. Not “underperformed” — failed.
- Alkaline chemistry didn’t work
- Flow rates were inconsistent
- The CPP wasn’t fit for purpose
- The contract book boxed the company in
- Leadership couldn’t execute
It was a structural failure, not a speed bump. But the underlying resource was real, so I held.
Phase 2 — The Hard Reset (2024–2025)
This is where the company finally admitted reality and rebuilt from the ground up — and where the downgrades hit.
The reset wasn’t clean. It came with:
- multiple production downgrades
- revised timelines
- a full re‑evaluation of wellfield design
- a complete rewrite of the ramp curve
This wasn’t a pivot — it was a controlled demolition.
But it also brought the changes the company had avoided for years:
- New CEO, CFO, and board
- Alkaline abandoned, low‑pH adopted
- CPP rebuilt and expanded
- Contract book torn down
- A$69.9M raised, US$15M debt secured
Painful, necessary, overdue.
Phase 3 — Finally Moving Forward (Late 2025–2026)
The ramp up is still slow, but for the first time since I invested, Peninsula is behaving like an operator.
- First dried yellowcake produced
- Permanent piping solution installed
- MU‑4 acidification ahead of schedule
- Flow rates beating plan
- Uranium grades hitting 352 mg/L — a project record
- CY26 guidance reaffirmed
I’ve watched this company at its lowest, so I recognise the shift — all be it slower than I’d like.
Disclosure: I hold! Also hold BOE, PDN. Share price swings widely